secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hypha Labs, Inc. (FUNI)
CIK:        0001502966
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001493152-23-015225
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Digipath agrees to sell cannabis testing lab assets for $2.3M; director resigns
-------------------------------------------------------------------------------

- Asset purchase price $2.3M cash; adjustments based on working capital above/below $150K.
- Closing subject to Nevada Cannabis Compliance Board approval by June 30, 2024; either party may terminate.
- Buyer deposited $230K into escrow for 12-month indemnification post-closing.
- Management Services Agreement: buyer manages lab; monthly fee $10K + 15% of cash collections to Digipath (min $15K).
- Director Bruce Raben resigned effective May 2, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1502966/000149315223015225/0001493152-23-015225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1502966/000149315223015225/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-015225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer